Literature DB >> 16709229

Trypanosoma cruzi: clones isolated from the Colombian strain, reproduce the parental strain characteristics, with ubiquitous histotropism.

Edson Camandaroba1, Torriceli S Thé, Daniel Huber Pessina, Sonia G Andrade.   

Abstract

Clonal histotropism and biological characters of five clones isolated during the early acute phase of the infection of Swiss mice with the Colombian strain of Trypanosoma cruzi (T. cruzi I), Biodeme Type III, were investigated. Clones were isolated from mice at the 10th and the 30th day of infection with the Colombian strain. Isolation was performed by micromanipulation and injection of one trypomatigote blood form into newborn mice, followed by passages into suckling mice for obtaining the inocula for the experimental groups. Mice infected with parental strain were also studied. All the clones have shown the basic characteristics of Biodeme Type III, with the same patterns of parasitemia, tissue tropism, morphological characters and isoenzymic profiles, such as the parental strain. Histotropism was most intense to myocardium and skeletal muscles, with intense lesions found in the advanced phase (20th to 30th day of infection). Both parental strain and the clones were seen to parasitize several organs and tissues; amastigote nests were identified in the cytoplasm of macrophages, adipose cells, smooth muscle of intestinal wall and Auerbach's neuronal plexus. The findings of the present study confirm the homology of the clones isolated from the Colombian strain, with predominance of a 'principal clone' and an ubiquitous distribution of parasites belonging to a same clone.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709229      PMCID: PMC2517366          DOI: 10.1111/j.1365-2613.2006.00476.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  28 in total

Review 1.  Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature.

Authors:  H Momen
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

2.  Trypanosoma cruzi: zymodemes associated with acute and chronic Chagas' disease in central Brazil.

Authors:  A O Luquetti; M A Miles; A Rassi; J M de Rezende; A A de Souza; M M Póvoa; I Rodrigues
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

3.  PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease.

Authors:  A R Vago; A M Macedo; S J Adad; D D Reis; R Corrêa-Oliveira
Journal:  Lancet       Date:  1996-09-28       Impact factor: 79.321

4.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease.

Authors:  A M Macedo; S D Pena
Journal:  Parasitol Today       Date:  1998-03

5.  Characterization of subpopulations (clones and subclones) of the 21 SF strain of Trypanosoma cruzi after long lasting maintenance in the laboratory.

Authors:  R M Campos; S G Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  1996 Nov-Dec       Impact factor: 2.743

6.  Kinetoplast DNA signatures of Trypanosoma cruzi strains obtained directly from infected tissues.

Authors:  A R Vago; A M Macedo; R P Oliveira; L O Andrade; E Chiari; L M Galvão; D Reis; M E Pereira; A J Simpson; S Tostes; S D Pena
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  Trypanosoma cruzi: biological characterization of 19 clones derived from two chronic chagasic patients. I. Growth kinetics in liquid medium.

Authors:  J C Engel; J A Dvorak; E L Segura; M S Crane
Journal:  J Protozool       Date:  1982-11

8.  Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains.

Authors:  S G Andrade; A Rassi; J B Magalhaes; F Ferriolli Filho; A O Luquetti
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

9.  Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain.

Authors:  V Andrade; M Barral-Netto; S G Andrade
Journal:  Braz J Med Biol Res       Date:  1985       Impact factor: 2.590

10.  Trypanosoma cruzi: susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain.

Authors:  Edson L P Camandaroba; Eliana A G Reis; Marilda S Gonçalves; Mitermayer G Reis; Sonia G Andrade
Journal:  Rev Soc Bras Med Trop       Date:  2003-06-10       Impact factor: 1.581

View more
  5 in total

1.  Renovascular hypertension increases serum TNF and CX3CL1 in experimental Trypanosoma cruzi infection.

Authors:  M C Silva; M A Azevedo; V P Figueiredo; M R Moura Junior; D Coelho Junior; P M Martinelli; R P Machado; A C Alzamora; A Talvani
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

2.  Cytokine-dependent and-independent gene expression changes and cell cycle block revealed in Trypanosoma cruzi-infected host cells by comparative mRNA profiling.

Authors:  Jaime A Costales; Johanna P Daily; Barbara A Burleigh
Journal:  BMC Genomics       Date:  2009-05-29       Impact factor: 3.969

Review 3.  Putting Infection Dynamics at the Heart of Chagas Disease.

Authors:  Michael D Lewis; John M Kelly
Journal:  Trends Parasitol       Date:  2016-09-06

4.  Correlation of Parasite Burden, kDNA Integration, Autoreactive Antibodies, and Cytokine Pattern in the Pathophysiology of Chagas Disease.

Authors:  Moisés Wesley; Aline Moraes; Ana de Cássia Rosa; Juliana Lott Carvalho; Tatiana Shiroma; Tamires Vital; Nayra Dias; Bruna de Carvalho; Doralina do Amaral Rabello; Tatiana Karla Dos Santos Borges; Bruno Dallago; Nadjar Nitz; Luciana Hagström; Mariana Hecht
Journal:  Front Microbiol       Date:  2019-08-21       Impact factor: 5.640

5.  The Colombian Strain of Trypanosoma cruzi Induces a Proinflammatory Profile, Neuronal Death, and Collagen Deposition in the Intestine of C57BL/6 Mice Both during the Acute and Early Chronic Phase.

Authors:  José Rodrigues do Carmo Neto; Arthur Wilson Florêncio da Costa; Yarlla Loyane Lira Braga; Fernanda Hélia Lucio; Ana Luisa Monteiro Dos Santos Martins; Marlene Antônia Dos Reis; Flávia Aparecida de Oliveira; Mara Rúbia Nunes Celes; Marcos Vinicius da Silva; Milton Adriano Pelli Oliveira; Juliana Reis Machado
Journal:  Mediators Inflamm       Date:  2022-01-12       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.